Annual Total Long Term Liabilities
$2.22 B
+$110.96 M+5.26%
December 31, 2024
Summary
- As of March 7, 2025, PTCT annual total long term liabilities is $2.22 billion, with the most recent change of +$110.96 million (+5.26%) on December 31, 2024.
- During the last 3 years, PTCT annual total long term liabilities has risen by +$794.84 million (+55.69%).
- PTCT annual total long term liabilities is now at all-time high.
Performance
PTCT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.22 B
-$63.76 M-2.79%
December 31, 2024
Summary
- As of March 7, 2025, PTCT quarterly total long term liabilities is $2.22 billion, with the most recent change of -$63.76 million (-2.79%) on December 31, 2024.
- Over the past year, PTCT quarterly long term liabilities has increased by +$113.11 million (+5.36%).
- PTCT quarterly long term liabilities is now -2.83% below its all-time high of $2.29 billion, reached on June 30, 2024.
Performance
PTCT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PTCT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.3% | +5.4% |
| 3 y3 years | +55.7% | +54.5% |
| 5 y5 years | +180.0% | +54.5% |
PTCT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.7% | -2.8% | +60.6% |
| 5 y | 5-year | at high | +180.0% | -2.8% | +216.4% |
| alltime | all time | at high | >+9999.0% | -2.8% | >+9999.0% |
PTC Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.22 B(+5.3%) | $2.22 B(-2.8%) |
| Sep 2024 | - | $2.29 B(-0.0%) |
| Jun 2024 | - | $2.29 B(+8.4%) |
| Mar 2024 | - | $2.11 B(-0.1%) |
| Dec 2023 | $2.11 B(+28.2%) | $2.11 B(+46.8%) |
| Sep 2023 | - | $1.44 B(-0.2%) |
| Jun 2023 | - | $1.44 B(-11.3%) |
| Mar 2023 | - | $1.62 B(-1.3%) |
| Dec 2022 | $1.65 B(+15.4%) | $1.65 B(+19.0%) |
| Sep 2022 | - | $1.38 B(-2.5%) |
| Jun 2022 | - | $1.42 B(+0.4%) |
| Mar 2022 | - | $1.41 B(-1.0%) |
| Dec 2021 | $1.43 B(-1.5%) | $1.43 B(-0.7%) |
| Sep 2021 | - | $1.44 B(-8.5%) |
| Jun 2021 | - | $1.57 B(+0.2%) |
| Mar 2021 | - | $1.57 B(+8.2%) |
| Dec 2020 | $1.45 B(+82.6%) | $1.45 B(+2.3%) |
| Sep 2020 | - | $1.42 B(+101.7%) |
| Jun 2020 | - | $702.30 M(-12.1%) |
| Mar 2020 | - | $799.19 M(+0.7%) |
| Dec 2019 | $793.60 M(+31.9%) | $793.60 M(-0.1%) |
| Sep 2019 | - | $794.33 M(+26.3%) |
| Jun 2019 | - | $628.93 M(+0.2%) |
| Mar 2019 | - | $627.92 M(+4.4%) |
| Dec 2018 | $601.70 M | $601.70 M(+14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $527.62 M(+234.2%) |
| Jun 2018 | - | $157.90 M(+1.0%) |
| Mar 2018 | - | $156.39 M(+2.1%) |
| Dec 2017 | $153.17 M(+53.0%) | $153.17 M(+2.2%) |
| Sep 2017 | - | $149.94 M(+3.1%) |
| Jun 2017 | - | $145.36 M(+42.0%) |
| Mar 2017 | - | $102.40 M(+2.3%) |
| Dec 2016 | $100.14 M(+6.7%) | $100.14 M(+1.1%) |
| Sep 2016 | - | $99.07 M(+2.1%) |
| Jun 2016 | - | $97.03 M(+1.8%) |
| Mar 2016 | - | $95.34 M(+1.5%) |
| Dec 2015 | $93.89 M(+4023.6%) | $93.89 M(-1.4%) |
| Sep 2015 | - | $95.25 M(+4311.9%) |
| Jun 2015 | - | $2.16 M(-5.9%) |
| Mar 2015 | - | $2.29 M(+0.8%) |
| Dec 2014 | $2.28 M(+2.2%) | $2.28 M(+1.8%) |
| Sep 2014 | - | $2.24 M(+0.8%) |
| Jun 2014 | - | $2.22 M(-1.8%) |
| Mar 2014 | - | $2.26 M(+1.4%) |
| Dec 2013 | $2.23 M(-45.8%) | $2.23 M(-2.8%) |
| Sep 2013 | - | $2.29 M(-17.0%) |
| Jun 2013 | - | $2.76 M(-8.0%) |
| Mar 2013 | - | $3.00 M(-26.9%) |
| Dec 2012 | $4.11 M(-98.3%) | $4.11 M |
| Dec 2011 | $239.61 M | - |
FAQ
- What is PTC Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for PTC Therapeutics?
- What is PTC Therapeutics annual total long term liabilities year-on-year change?
- What is PTC Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for PTC Therapeutics?
- What is PTC Therapeutics quarterly long term liabilities year-on-year change?
What is PTC Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PTCT is $2.22 B
What is the all time high annual total long term liabilities for PTC Therapeutics?
PTC Therapeutics all-time high annual total long term liabilities is $2.22 B
What is PTC Therapeutics annual total long term liabilities year-on-year change?
Over the past year, PTCT annual total long term liabilities has changed by +$110.96 M (+5.26%)
What is PTC Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PTCT is $2.22 B
What is the all time high quarterly long term liabilities for PTC Therapeutics?
PTC Therapeutics all-time high quarterly total long term liabilities is $2.29 B
What is PTC Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, PTCT quarterly total long term liabilities has changed by +$113.11 M (+5.36%)